![James Randolph Hillard](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James Randolph Hillard
Chairman at Phase 2 Discovery, Inc.
James Randolph Hillard active positions
Companies | Position | Start | End |
---|---|---|---|
Phase 2 Discovery, Inc.
![]() Phase 2 Discovery, Inc. Pharmaceuticals: MajorHealth Technology Phase 2 Discovery, Inc. (P2D) develops central nervous system drugs. The company provides discovery research & development services for pharmaceutical and biotechnology companies. It also develops drugs for treating psychiatric and neurologic disorders. Its products include PD6735, the treatment of primary insomnia and additional indications, N-Substituted Analogs of Benztropine for the treatment of attention deficit hyperactivity disorder & Thiothalidomides and Hydroxythalidomides for the treatment of ALS and MS. Phase 2 Discovery was founded in 1998 and is headquartered in Cincinnati, OH. | Chairman | - | - |
President | - | - | |
University of Cincinnati (Ohio) | Corporate Officer/Principal | - | - |
Career history of James Randolph Hillard
Statistics
International
United States | 3 |
Operational
Chairman | 1 |
President | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Phase 2 Discovery, Inc.
![]() Phase 2 Discovery, Inc. Pharmaceuticals: MajorHealth Technology Phase 2 Discovery, Inc. (P2D) develops central nervous system drugs. The company provides discovery research & development services for pharmaceutical and biotechnology companies. It also develops drugs for treating psychiatric and neurologic disorders. Its products include PD6735, the treatment of primary insomnia and additional indications, N-Substituted Analogs of Benztropine for the treatment of attention deficit hyperactivity disorder & Thiothalidomides and Hydroxythalidomides for the treatment of ALS and MS. Phase 2 Discovery was founded in 1998 and is headquartered in Cincinnati, OH. | Health Technology |